Polynucleotide training in the UK

Most established training providers and product distributors require candidates to be regulated healthcare professionals — doctors, dentists, registered nurses, midwives, pharmacists and, for some courses, other allied professionals — usually with existing experience of injectable treatments.

Some providers do accept non-medical candidates, which is possible because the law does not currently restrict who may inject a non-prescription device in England. The JCCP and other bodies have argued for restricting higher-risk procedures to appropriately qualified practitioners, and the proposed licensing scheme is expected to move in that direction.

Prior training in facial anatomy, aseptic technique, consent, basic life support and complication management is the foundation. Polynucleotide training builds on that; it is not a substitute for it.

• The science of polynucleotides and PDRN, and the limits of the evidence.
• Product ranges, indications, contraindications and storage.
• Patient selection, consultation, photography and realistic expectations.
• Facial anatomy relevant to superficial injection, with particular attention to the periorbital region.
• Injection technique: needle and cannula approaches, depth, pattern and volume.
• Treatment planning, session intervals and maintenance.
• Recognising and managing complications, including infection, nodules and vascular events.
• Consent, record keeping, insurance and advertising rules.
• Supervised practice on live models.

A course without hands-on supervised practice and without a substantial complications component is not adequate preparation.

There is no single mandatory qualification. The reference points that carry weight are:

• JCCP / CPSA standards for education and practice in non-surgical cosmetic procedures, including the qualification levels expected for different procedures.
• Ofqual-regulated qualifications, typically at Level 7 for injectable practice, delivered by recognised awarding organisations.
• CPD accreditation, which confirms a course meets continuing professional development criteria but is a weaker signal than a regulated qualification.
• Manufacturer training, which is product-specific and useful, but narrow by design and commercially motivated.

Indemnity insurers will generally want evidence of appropriate training before covering a new procedure, so checking with your insurer before booking a course is sensible.

• What qualification or accreditation does this course carry, and who awards it?
• What are the entry requirements, and who else will be on the course?
• How many live models will I treat, and what is the trainer-to-delegate ratio?
• Who are the trainers, and what is their clinical background?
• How much time is devoted to complications and emergency management?
• Is the course tied to a single brand or does it cover the category?
• What post-course support, mentoring or assessment is included?
• Will my insurer accept this certificate? Have you checked with major insurers?

For the regulatory background, see who can administer polynucleotides in the UK.